T. MIYASAKA

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

Masanori Baba, H. TANAKA, Erik De Clercq et al. · Biochemical and Biophysical Research Communications · 1989 · 288 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro

Masanori Baba, Shirô Shigeta, Satoshi Yuasa et al. · Antimicrobial Agents and Chemotherapy · 1994 · 118 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

A Convenient Method for the Selective Acylation of Guanine Nucleosides

Akira Matsuda, Misao Shinozaki, Mamoru Suzuki et al. · Synthesis · 1986 · 61 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

Synthesis of CPT‐11 (Irinotecan Hydrochloride Trihydrate)

Sadao Sawada, Teruo Yokokura, T. MIYASAKA · Annals of the New York Academy of Sciences · 1996 · 34 citations

Natural Sciences, Chemistry, Medicinal Chemistry +5

Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro

Masanori Baba, Masahiko Ito, Shirô Shigeta et al. · Antimicrobial Agents and Chemotherapy · 1991 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14